Trametinib | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Trametinib | hsa00230 | Purine metabolism | 3.35E-02 | 2 | Q7LG56, P51828 | RRM2B, ADCY7 | More | |
Trametinib | hsa00330 | Arginine and proline metabolism | 2.73E-02 | 1 | P17707 | AMD1 | More | |
Trametinib | hsa00500 | Starch and sucrose metabolism | 1.91E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
Trametinib | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.11E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | |
Trametinib | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | |
Trametinib | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Trametinib | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Trametinib | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | |
Trametinib | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | |
Trametinib | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
Trametinib | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Trametinib | hsa00750 | Vitamin B6 metabolism | 4.45E-02 | 1 | O00764 | PDXK | More | |
Trametinib | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Trametinib | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Trametinib | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Trametinib | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | |
Trametinib | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.91E-02 | 1 | P50213 | IDH3A | More | |
Trametinib | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | |
Trametinib | hsa03013 | RNA transport | 3.52E-02 | 4 | P52298, O14893, O14602, P78345 | NCBP2, GEMIN2, EIF1AY, RPP38 | More | |
Trametinib | hsa04064 | NF-kappa B signaling pathway | 2.71E-03 | 11 | P10415, O00463, Q13546, P14778, Q9UDY8, Q13077, Q16548, Q8WV28, Q13315, P24522, P09341 | BCL2, TRAF5, RIPK1, IL1R1, MALT1, TRAF1, BCL2A1, BLNK, ATM, GADD45A, CXCL1 | More | |
Trametinib | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | |
Trametinib | hsa04114 | Oocyte meiosis | 2.05E-02 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | |
Trametinib | hsa04115 | p53 signaling pathway | 2.54E-02 | 3 | O15151, Q13315, P10415 | MDM4, ATM, BCL2 | More | |
Trametinib | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Trametinib | hsa04137 | Mitophagy - animal | 1.41E-03 | 3 | P67870, P19532, P18848 | CSNK2B, TFE3, ATF4 | More | |
Trametinib | hsa04145 | Phagosome | 4.79E-02 | 3 | P14598, Q13509, P68371 | NCF1, TUBB3, TUBB2C | More | |
Trametinib | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
Trametinib | hsa04370 | VEGF signaling pathway | 1.29E-02 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
Trametinib | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | |
Trametinib | hsa04390 | Hippo signaling pathway | 4.35E-02 | 2 | P63261, O15105 | ACTG1, SMAD7 | More | |
Trametinib | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | |
Trametinib | hsa04530 | Tight junction | 3.60E-03 | 5 | P63261, P16989, P56750, Q92974, Q14247 | ACTG1, CSDA, CLDN17, ARHGEF2, CTTN | More | |
Trametinib | hsa04540 | Gap junction | 7.81E-03 | 3 | Q13509, P68371, Q9NRA1 | TUBB3, TUBB2C, PDGFC | More | |
Trametinib | hsa04613 | Neutrophil extracellular trap formation | 1.73E-02 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Trametinib | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | |
Trametinib | hsa04640 | Hematopoietic cell lineage | 4.95E-02 | 3 | P01730, P06127, P09564 | CD4, CD5, CD7 | More | |
Trametinib | hsa04657 | IL-17 signaling pathway | 1.88E-03 | 6 | O00463, Q16539, P49841, P09341, P14780, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, TNF | More | |
Trametinib | hsa04664 | Fc epsilon RI signaling pathway | 3.98E-02 | 3 | P01375, Q16539, Q9UQC2 | TNF, MAPK14, GAB2 | More | |
Trametinib | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | |
Trametinib | hsa04720 | Long-term potentiation | 3.73E-02 | 2 | Q15418, P18848 | RPS6KA1, ATF4 | More | |
Trametinib | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
Trametinib | hsa04727 | GABAergic synapse | 4.60E-02 | 2 | P51828, P46459 | ADCY7, NSF | More | |
Trametinib | hsa04912 | GnRH signaling pathway | 3.96E-02 | 2 | P51828, P45985 | ADCY7, MAP2K4 | More | |
Trametinib | hsa04914 | Progesterone-mediated oocyte maturation | 2.66E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | |
Trametinib | hsa04918 | Thyroid hormone synthesis | 4.48E-02 | 2 | P18848, P05543 | ATF4, SERPINA7 | More | |
Trametinib | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | |
Trametinib | hsa04935 | Growth hormone synthesis, secretion and action | 4.60E-02 | 2 | P51828, P45985 | ADCY7, MAP2K4 | More | |
Trametinib | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Trametinib | hsa05010 | Alzheimer disease | 3.57E-02 | 4 | P13073, P18848, P67870, P05141 | COX4I1, ATF4, CSNK2B, SLC25A5 | More | |
Trametinib | hsa05020 | Prion disease | 3.29E-02 | 4 | P13073, P18848, P05141, P67870 | COX4I1, ATF4, SLC25A5, CSNK2B | More | |
Trametinib | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.95E-02 | 2 | Q06055, O15020 | ATP5G2, SPTBN2 | More | |
Trametinib | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Trametinib | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.45E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | |
Trametinib | hsa05130 | Pathogenic Escherichia coli infection | 4.08E-02 | 3 | Q15438, P35579, P55061 | PSCD1, MYH9, TEGT | More | |
Trametinib | hsa05131 | Shigellosis | 1.80E-02 | 5 | Q13546, Q9UDY8, Q12778, Q13315, P10415 | RIPK1, MALT1, FOXO1, ATM, BCL2 | More | |
Trametinib | hsa05132 | Salmonella infection | 4.85E-02 | 4 | Q13546, P10415, Q13509, P68371 | RIPK1, BCL2, TUBB3, TUBB2C | More | |
Trametinib | hsa05140 | Leishmaniasis | 2.69E-02 | 5 | O75015, P13765, O60603, P49006, Q16539 | FCGR3B, HLA-DOB, TLR2, MARCKSL1, MAPK14 | More | |
Trametinib | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
Trametinib | hsa05146 | Amoebiasis | 4.55E-02 | 5 | P09341, P14778, P27930, O60603, P05089 | CXCL1, IL1R1, IL1R2, TLR2, ARG1 | More | |
Trametinib | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
Trametinib | hsa05163 | Human cytomegalovirus infection | 3.04E-03 | 8 | P01375, Q14643, P49841, P14778, P25025, Q16539, P04637, O00463 | TNF, ITPR1, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5 | More | |
Trametinib | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | |
Trametinib | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Trametinib | hsa05215 | Prostate cancer | 3.03E-02 | 3 | P10415, Q12778, Q9NRA1 | BCL2, FOXO1, PDGFC | More | |
Trametinib | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | |
Trametinib | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | |
Trametinib | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.55E-02 | 5 | O95267, P09693, O60603, Q16539, P01730 | RASGRP1, CD3G, TLR2, MAPK14, CD4 | More | |
Trametinib | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Trametinib | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Trametinib | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Trametinib | hsa05418 | Fluid shear stress and atherosclerosis | 1.26E-04 | 8 | Q16539, Q14145, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | |